{{Rsnum
|rsid=1124376
|Gene=KAT2B
|Chromosome=3
|position=20067054
|Orientation=plus
|GMAF=0.09734
|Gene_s=KAT2B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 31.0 | 66.4
| HCB | 0.0 | 1.5 | 98.5
| JPT | 0.0 | 0.9 | 99.1
| YRI | 0.0 | 3.4 | 96.6
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.0 | 1.5 | 98.5
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 16.0 | 84.0
| LWK | 0.0 | 4.6 | 95.4
| MEX | 0.0 | 17.2 | 82.8
| MKK | 1.3 | 14.1 | 84.6
| TSI | 4.0 | 46.5 | 49.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=20889312
  |Trait=Bipolar disorder and schizophrenia
  |Title=A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.
  |RiskAllele=
  |Pval=5E-6
  |OR=1.28
  |ORtxt=[NR]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}